breast cancer
Conditions
Interventions
Acupuncture group (Acupuncture treatment including manual acupuncture, electroacupuncture, acupoint pressure, moxibustion, warm acupuncture, ear acupuncture, ear point pressure, etc.):None
Conventional treatment group (western medicine alone, including Selective serotonin reuptake inhibitors (SSIR), selective serotonin and norepinephrine reuptake inhibitors (SNRI), clonidine, etc.):None
Sponsors
Institute Of Basic Research In Clinical Medicine, China Academy Of Chinese Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Female, 18-80 years old, breast cancer diagnosed by the Breast Cancer Clinical Practice Guidelines (2023.V4) published by the National Comprehensive Cancer Network or CACA Guidelines for Holistic Integrative Management of Cancer (2023), pathologically suggested to be hormone receptor-positive breast cancer (ER+ or PR+) 2. Receive at least hormone therapy more than 1 month. Such as, Tamoxifen, Fulvestrant, Anastroxa, etc. 3. The patient has one of the secondary symptoms in addition to the main symptoms of menopausal syndrome. Main symptoms: hot flashes and night sweats: an average of 7 or more times a day, with moderate or severe hot flashes and night sweats. Secondary symptoms include: sleep disturbance: Pittsburgh Sleep Quality Index (PSQI) score = 7 points; fatigue: overall fatigue standard score = 3 points on the Fatigue Self-Rating Scale; depression: HADS-A score on the Hospital Anxiety and Depression Scale Anxiety: A HADS-D score of =8 on the Hospital Anxiety and Depression Scale is considered a depressive symptom. 4. Adhere to outpatient treatment for a long time and sign informed consent
Exclusion criteria
Exclusion criteria: Any occurrence of any of the following items shall be excluded: 1. Those with a history of uterine surgery or bilateral oophorectomy, premature ovarian failure, gonadal dysplasia, etc. 2. Chemotherapy-induced amenorrhea =12 months, and continuous monitoring of FSH and estradiol during chemotherapy treatment is in the postmenopausal range. 3. Menopausal-like syndrome caused by the combination of multiple cancers. 4. Those combined with serious cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic, endocrine system and mental diseases. 5. Those who have participated in other clinical studies in the past three months. 6. Those who are unconscious and unable to express subjective symptoms of discomfort. 7. Do not agree to sign the informed consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hot Flash Score (HFS);the score on the Pittsburgh Sleep Quality Index Scale (PSQI);the score on the Fatigue Self-assessment Scale (FSAS);the score of the Hospital Anxiety and Depression Scale (HADS); | — |
Secondary
| Measure | Time frame |
|---|---|
| the number of adverse events of acupuncture; | — |
Countries
China
Contacts
Public ContactTianyi Zhao
School of Chinese Medicine, Tianjin University of Chinese Medicine
Outcome results
None listed